Tidence Prince, MD
Allergy & Immunology · Maryville, TNNPI 1215922356
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $202,177 of the $269,233 with a category attached, or 75.1%. It is spread thinly across 39 manufacturers, the largest accounting for just 23.7%. Among allergy & immunology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,169 payments — averaging $230.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$64K
- GSK$52K
- CSL Behring$32K
- Shire North American Group Inc$19K
- ARS Pharmaceuticals Operations, Inc.$19K
- Regeneron Healthcare Solutions, Inc.$14K
- plus $69K from 33 others
Across 2 payments — averaging $17,119 each. An ownership or investment interest held by the physician or an immediate family member.
- Consortium Of Independent Immunology Clinics, LLC$34K
What the payments were for
- Consulting fees$28,83911%
- Speaking & faculty fees$202,17775%
- Travel & lodging$10,9894%
- Food & beverage$26,94310%
- Education$2850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$269,233 in reported general payments places this provider in the 95th percentile of 79 allergy & immunology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 125 | $671,777 |
| HyqviaIgg/Hyaluronidase,recombinant | 122 | $630,150 |
| HaegardaC1 Esterase Inhibitor | 12 | $279,286 |
| XolairOmalizumab | 53 | $175,490 |
| CinqairReslizumab | 21 | $100,701 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 104 | $95,196 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 29 | $94,901 |
| Dupixent SyringeDupilumab | 14 | $52,230 |
| Breo ElliptaFluticasone/Vilanterol | 75 | $46,108 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $15,951 |
| Epinephrine | 60 | $12,417 |
| Azelastine Hcl | 350 | $11,162 |
| SymbicortBudesonide/Formoterol Fumarate | 18 | $9,954 |
| Advair HfaFluticasone Propion/Salmeterol | 13 | $9,668 |
| Fluticasone Propionate | 401 | $6,602 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra, Haegarda | $32,185 | $951,062137 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Hyqvia | $12,285 | $630,150122 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $52,003 | $141,304179 claims |
| Teva Pharmaceuticals USA, Inc.Cinqair, Qvar Redihaler | $186 | $104,58735 claims |
| Grifols USA, LLCGamunex-C | $921 | $94,90129 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $63,865 | $25,90541 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 79 allergy & immunology providers in Tennessee.
Other allergy & immunology in Maryville
- Karthik KrishnanMaryville$10K
- Wilson RobinsonMaryville$7K
- Nicholas KolinskyKnoxville$472K
- Tammy Heinly McCulleyGermantown$165K
- Phillip LiebermanMemphis$131K
- John FahrenholzNashville$124K
- Marc CromieChattanooga$106K
- Reena PatelMemphis$101K
- Jay LiebermanMemphis$81K
- Katherine CahillNashville$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.